Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEAL-COVID
NCT04801940Phase 3Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban, atorvastatin in coronavirus disease 2019 (COVID-19), sponsored by Cambridge University Hospitals NHS Foundation Trust. Status: unknown.
02
Drugs
apixabanatorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04801940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801940.